Key opinion leaders share their perspectives on innovations in cancer research recorded at AACR 2018.
Convergence of technology and cancer research
AACR President-elect Elaine Mardis, PhD, shares insight into the notion of convergence of technology and cancer research being discussed at this year’s meeting.
Daniel Silver, MD, PhD, of Sidney Kimmel Cancer Center at Jefferson Health, describes his interest in the potential to augment current immunotherapy approaches with new drugs and targeted therapies that may enhance immunotherapy action.
Innovative cancer science
What is “innovative” cancer science? AACR President-elect Elaine Mardis, PhD, explains.
Power of genomics
“The power of genomics has allowed us insight into cancer that we really hadn’t had the possibility of knowing before,” says Dr. Daniel Silver, Sidney Kimmel Cancer Center at Jefferson Health.
Pace of progress in cancer research
Describing a continued rapid pace of progress in cancer research, AACR President-elect Elaine Mardis, PhD, explains: “We have the convergence of data, know-how, computing infrastructure and people becoming involved in cancer science who historically had not been a part of it.”
Impact of big data
Will the rapid pace of progress continue? Yes, says Daniel Silver, MD, PhD, who predicts big data, and in particular genomic data, across many cancer patients is going to “continue to inform our understanding of cancer and help us develop new therapies.”